| Literature DB >> 31131361 |
Noriyuki Egawa1, Jun Nakamura1, Tatsuya Manabe1, Hironori Iwasaki1, Hirokazu Noshiro1.
Abstract
AIM: The present study was designed to evaluate the safety and feasibility of transabdominal preperitoneal (TAPP) repair for very old patients with groin hernia and to identify the risk factors predicting perioperative complications.Entities:
Keywords: elderly; groin hernia; transabdominal preperitoneal
Year: 2019 PMID: 31131361 PMCID: PMC6524104 DOI: 10.1002/ags3.12247
Source DB: PubMed Journal: Ann Gastroenterol Surg ISSN: 2475-0328
Figure 1Study flow chart. OHS, open hernia surgery; TAPP, transabdominal preperitoneal
Characteristics of TAPP repair patients
| ≥80 y group (n = 26) | <80 y group (n = 114) |
| |
|---|---|---|---|
| Gender, male/female | 22/4 | 98/16 | 0.766 |
| Age (y, mean ± SD) | 83.6 ± 3.1 | 64.3 ± 13.4 | <0.001 |
| BMI (kg/m2, mean ± SD) | 21.6 ± 2.7 | 22.5 ± 2.7 | 0.101 |
| Performance status (0‐2/3‐4) | 23/3 | 109/5 | 0.167 |
| ASA classification (1‐2/3‐4) | 25/1 | 111/3 | 0.565 |
| Blood test | |||
| Hb (mg/dL, mean ± SD) | 12.8 ± 1.6 | 13.7 ± 2.7 | 0.038 |
| Alb (mg/dL, mean ± SD) | 3.7 ± 0.4 | 4.0 ± 0.5 | 0.016 |
| Diseased side (unilateral/bilateral) | 25/1 | 100/14 | 0.304 |
| Type of groin hernia | 21/5/1/0 | 93/28/2/5 | 0.635 |
| Size of hernia orifice | 20/6 | 98/16 | 0.392 |
| Emergency operation, n (%) | 2 (7.7) | 2 (1.8) | 0.157 |
| Recurrent case, n (%) | 3 (11.5) | 11 (9.7) | 0.724 |
| History of other side inguinal hernia repair | 3 (12.0) | 17 (17.0) | 0.762 |
| History of abdominal surgery, n (%) | 14 (53.9) | 41 (36.0) | 0.12 |
| History of prostatectomy | 2 (9.1) | 9 (9.2) | 1.000 |
| Antithrombotic therapy, n (%) | 9 (34.6) | 27 (23.7) | 0.319 |
| Steroid therapy, n (%) | 0 (0.0) | 4 (3.5) | 1.000 |
| Comorbidity, n (%) | 25 (96.2) | 70 (61.4) | 0.003 |
| Circulatory disease, n (%) | 9 (34.6) | 26 (22.8) | 0.218 |
| Renal dysfunction, n (%) | 15 (57.7) | 23 (20.2) | 0.003 |
| Pulmonary dysfunction, n (%) | 14 (53.9) | 18 (15.8) | <0.001 |
| Liver disease, n (%) | 2 (7.7) | 12 (10.5) | 1.000 |
| Cerebral infarction, n (%) | 6 (23.1) | 4 (3.5) | 0.003 |
| Diabetes, n (%) | 7 (26.9) | 18 (15.8) | 0.254 |
| Dementia, n (%) | 2 (7.7) | 2 (1.8) | 0.157 |
| Surgeon (resident/expert | 17/9 | 64/50 | 0.385 |
Alb, albumin; ASA, American Society of Anesthesiologists; BMI, body mass index; Hb, hemoglobin; PS, performance status; TAPP, transabdominal preperitoneal.
Including bilateral cases. Described according to European Hernia Society classification.
In bilateral cases, the larger size of defect was listed. Board Certified Surgeon in Gastroenterology.
Excluding bilateral cases.
Excluding female cases.
Board‐certified surgeon in gastroenterology of the Japanese Society of Gastroenterological Surgery.
Surgical outcomes and perioperative complications of TAPP repair patients
| ≥80 y group (n = 26) | <80 y group (n = 114) |
| |
|---|---|---|---|
| Operation time (min), mean ±SD | 125.8 ± 40.4 | 137.5 ± 45.7 | 0.230 |
| Conversion to open surgery, n (%) | 0 (0) | 1 (0.9) | 1.000 |
| Blood loss (g), mean ± SD | 0.9 ± 2.1 | 1.5 ± 4.5 | 0.510 |
| Postoperative hospitalization (d), mean ± SD | 3.8 ± 1.4 | 3.3 ± 1.6 | 0.140 |
| Perioperative complications | 9 (34.6) | 22 (19.3) | 0.116 |
| Intraoperative complications, n (%) | 0 (0) | 1 (0.9) | 1.000 |
| Other organ injury | 0 (0) | 1 (0.9) | 1.000 |
| Postoperative complications, n (%) | 9 (34.6) | 21 (18.4) | 0.109 |
| Seroma | 5 (19.2) | 19 (16.7) | 0.775 |
| Hematoma | 3 (11.5) | 0 (0) | 0.006 |
| Wound infection | 0 (0) | 0 (0) | – |
| Pneumonia | 0 (0) | 1 (0.9) | 1.000 |
| Cystitis | 0 (0) | 1 (0.9) | 1.000 |
| Other | 1 (3.8) | 0 (0) | 0.186 |
| Inguinal pain and/or discomfort | 0 (0) | 7 (6.1) | 0.348 |
TAPP, transabdominal preperitoneal.
Complications grade 2 or higher according to the Clavien‐Dindo classification.
Observation at 1 mo after surgery.
Univariate and multivariate analyses of perioperative complications in TAPP repair patients
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| Complications | Complications (−) (n = 109) |
| OR | 95% CI |
| |
| Age (≥80 y/<80 y) | 9/22 | 17/92 | 0.116 | |||
| Gender (male/female) | 30/1 | 90/19 | 0.076 | |||
| BMI (kg/m2, mean ± SD) | 22.1 ± 2.4 | 22.4 ± 2.8 | 0.511 | |||
| Performance status (0‐2/3‐4) | 26/5 | 106/3 | 0.014 | 5.192 | 1.137‐23.71 | 0.034 |
| ASA classification (1‐2/3‐4) | 30/1 | 106/3 | 1.000 | |||
| Blood test | ||||||
| Hb (mg/dL, mean ± SD) | 12.9 ± 1.9 | 13.7 ± 1.8 | 0.036 | 1.130 | 0.864‐1.479 | 0.371 |
| Alb (mg/dL, mean ± SD) | 3.8 ± 0.4 | 4.0 ± 0.5 | 0.035 | 1.821 | 0.604‐5.493 | 0.287 |
| Type of groin hernia | 25/10/0/0 | 89/23/3/5 | 0.420 | |||
| Diseased side (unilateral/bilateral) | 27/4 | 98/11 | 0.742 | |||
| Size of hernia orifice | 24/7 | 92/17 | 0.419 | |||
| Emergency operation (yes/no) | 1/30 | 3/106 | 1.000 | |||
| Recurrent case (yes/no) | 3/28 | 11/98 | 1.000 | |||
| History of laparotomy (yes/no) | 13/18 | 42/67 | 0.835 | |||
| Antithrombotic therapy (yes/no) | 9/22 | 27/82 | 0.646 | |||
| Steroid therapy (yes/no) | 2/29 | 2/107 | 0.213 | |||
| Comorbidity (yes/no) | 25/6 | 70/39 | 0.126 | |||
| Circulatory disease (yes/no) | 9/22 | 26/83 | 0.639 | |||
| Renal dysfunction (yes/no) | 8/23 | 30/79 | 1.000 | |||
| Pulmonary dysfunction (yes/no) | 10/21 | 22/87 | 0.224 | |||
| Liver disease (yes/no) | 4/27 | 10/99 | 0.511 | |||
| Cerebral infarction (yes/no) | 2/29 | 8/101 | 1.000 | |||
| Diabetes (yes/no) | 4/27 | 21/88 | 0.596 | |||
| Dementia (yes/no) | 2/29 | 2/107 | 0.213 | |||
| Surgeon, (resident/expert | 20/11 | 61/48 | 0.392 | |||
Alb, albumin; ASA, American Society of Anesthesiologists; BMI, body mass index; Hb, hemoglobin; TAPP, transabdominal preperitoneal.
Complications grade 2 or higher according to the Clavien‐Dindo classification.
Including bilateral cases. Described according to European Hernia Society classification.
In bilateral cases, the larger size of defect is listed.
Board‐certified surgeon in gastroenterology of the Japanese Society of Gastroenterological Surgery.